VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
LYELLyell Immunopharma, Inc.
$11.97$279M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksLYELPrice History

LYEL logoLyell Immunopharma, Inc. (LYEL) Stock Price History

Historical prices from 2021 to 2026

$11.97-0.77  (-6.04%)close Jun 22
Returns
1M
-22.8%
3M
-36.5%
YTD
-56.0%
1Y
+33.0%
3Y
-40.3%
5Y
-47.6%
ATH$396.80Sep 2021-97.0%
ATL$7.65Jun 2025pre-split
Avg Vol (50D)101K/ day
52-Week Range$8.46 — $45.00
LowCurrent: $11.97High

Loading 10-year price history...

LYEL Historical Performance

1 YearTotal Return
+33.0%
Price: +33.0%
3 YearsTotal Return
-78.7%
CAGR: -40.3%
Price: -78.7%
5 YearsTotal Return
-96.1%
CAGR: -47.6%
Price: -96.1%
YTD
-56.0%

LYEL Annual Returns

Year-by-year price performance · 2021–2026

Best+138.6%2025
Worst-69.7%2024
Up years1/6
2021-54.2%
2022-54.9%
2023-42.3%
2024-69.7%
2025+138.6%
2026-17.2%
2021 annual price return
-54.2%
2022 annual price return
-54.9%
2023 annual price return
-42.3%
2024 annual price return
-69.7%
2025 annual price return
+138.6%
2026 annual price return
-17.2%
LessMore
Alpha vs S&P 500
1Y+8.0%
3Y-60.2%
5Y-60.7%

Price returns only.

Download Historical Data

1,259 records • Includes OHLCV + Technical Indicators (MA50, MA200, RSI)

Free sign in required to download data

LYEL Stock Price Trajectory (2021–2026)

As of June 23, 2026, Lyell Immunopharma, Inc. (LYEL) trades at $11.97, representing a +33.0% return over the past year. The stock has delivered a -96.1% total return over five years (-47.6% CAGR), reflecting challenging market conditions.

The stock reached its all-time high of $396.80 on September 7, 2021. From this peak, LYEL has corrected -97.0%, currently trading 42% below its 200-day moving average, suggesting potential weakness.

When compared to Healthcare sector peers FATE (+72.7% 1Y), ADCT (-64.0% 1Y), and CABA (+64.2% 1Y), LYEL has underperformed the peer group average. Compare LYEL vs FATE →

LYEL Historical Price Data · from 2021

Rows 1–50 of 1,259
Date Open High Low Close Volume Change %
2026-06-2213.0613.0611.6711.97175K-6.04%
2026-06-1812.7313.2212.2412.74358K+1.76%
2026-06-1712.4813.0212.3512.52162K+0.64%
2026-06-1613.3613.4912.0312.44194K-8.19%
2026-06-1513.7813.9613.2713.5582K+0.37%
2026-06-1213.6713.8013.0813.5093K-1.60%
2026-06-1113.2214.1412.8313.72142K+3.78%
2026-06-1012.6413.4612.6413.22142K+4.09%
2026-06-0912.5013.0312.1712.7099K+3.17%
2026-06-0812.2012.4711.8512.31122K+2.84%
2026-06-0512.9912.9911.7011.9796K-8.28%
2026-06-0412.5913.1311.9513.05126K+3.82%
2026-06-0314.8614.8712.3712.57408K-15.58%
2026-06-0217.1517.1614.7114.89116K-13.18%
2026-06-0117.2317.6516.7417.1581K-1.04%
2026-05-2916.5517.4116.5517.3365K+2.97%
2026-05-2816.7717.0816.4116.8357K+0.60%
2026-05-2716.4317.2116.0216.7384K+2.20%
2026-05-2617.4617.6516.0916.37130K-6.24%
2026-05-2217.1917.6917.1917.4653K+0.92%
2026-05-2116.5917.5416.2117.3070K+0.46%
2026-05-2016.2617.3016.0017.2280K+6.76%
2026-05-1916.0016.4315.4916.13117K-2.30%
2026-05-1818.1218.1216.4116.5196K-7.87%
2026-05-1518.5618.7317.4317.92107K-5.78%
2026-05-1419.2519.4918.8419.0237K-1.14%
2026-05-1319.1019.4118.6419.2439K-0.05%
2026-05-1219.0719.5518.6819.2553K+0.26%
2026-05-1118.9120.7018.5519.2097K-0.67%
2026-05-0819.9320.3819.1419.3361K-3.64%
2026-05-0720.9421.2319.5320.0652K-3.79%
2026-05-0620.6721.2820.2020.8536K+1.12%
2026-05-0521.4521.4520.3220.6252K-0.48%
2026-05-0420.5721.4820.5720.7250K-0.53%
2026-05-0120.1121.2019.9320.8348K+5.58%
2026-04-3020.6421.5519.5919.7347K-4.22%
2026-04-2921.4821.4820.2920.6056K-4.14%
2026-04-2822.5223.6821.3221.4963K-5.00%
2026-04-2722.2623.2321.8922.6260K+0.94%
2026-04-2423.1423.6722.2522.4153K-5.04%
2026-04-2324.7624.8023.1223.6079K-4.76%
2026-04-2224.4024.7823.6524.7872K+3.66%
2026-04-2124.8024.9923.3323.9176K-3.96%
2026-04-2023.8725.0323.3824.89124K+3.67%
2026-04-1724.1524.6423.7524.0194K+1.31%
2026-04-1624.6024.6023.3023.7058K-0.59%
2026-04-1523.0224.2623.0223.8486K+2.01%
2026-04-1424.9024.9023.1823.37129K-5.77%
2026-04-1324.0225.0022.4824.80168K+10.76%
2026-04-1024.0024.2322.3922.39108K-6.12%
…
Consensus-Based Analysis Tools

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

DCA Calculator

See how regular investing compounds over time.

Run Numbers

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

LYEL — Frequently Asked Questions

Quick answers to the most common questions about buying LYEL stock.

How has LYEL stock performed recently?

LYEL returned +33.0% over the past year, beating its 5-year annualized CAGR of -47.6%. The stock trades below its 200-day moving average, confirming the uptrend.

What is LYEL's all-time high price?

Lyell Immunopharma, Inc. reached $396.80 on 2021-09-07. The 52-week high is $45.00. Current 1-year return of +33.0% places the stock closer to historical peaks.

Where can I download LYEL historical price data?

This page provides LYEL daily OHLCV data with 50-day MA, 200-day MA, and RSI indicators. Data spans 2021-2026, downloadable in CSV format.

421 data points · sampled from 1,259